From Medscape Gastroenterology

Coverage from the

International Liver Congress (ILC) 2019

April 10 - 14, 2019; Vienna, Austria

April 10 - 14, 2019 Vienna, Austria
  • ILC 2019 First Drug for Fatty Liver Disease Advances Obeticholic acid has hit a statistically significant result at 18 months in the REGENERATE trial evaluating the farnesoid X receptor agonist in patients with nonalcoholic steatohepatitis.

Conference News

Popular News From ILC 2018

Medscape Gastroenterology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage